Bleeding Risk in Atrial Fibrillation: HAS-BLED Score
Understand the risk of bleeding from anticoagulation in atrial fibrillation
About
The HAS-BLED score was derived from a real-world cohort of 3978 with AF and assesses the 1-year risk for major bleeding (intracranial, hospitalization, hemoglobin decrease >2 g/L, and/or transfusion) associated with oral anticoagulation. Patients with a high risk of bleeding (HAS-BLED score ≥ 3) should undergo regular clinical review following the initiation of oral anticoagulation.
References
Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY.
By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.